Related references
Note: Only part of the references are listed.CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data
Sabrina Khan et al.
CEPHALALGIA (2019)
Migraine and risk of cardiovascular diseases: Danish population based matched cohort study
Kasper Adelborg et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Migraine and risk of cardiovascular diseases: Danish population based matched cohort study
Kasper Adelborg et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Fibromyalgia Among Patients With Chronic Migraine and Chronic Tension-Type Headache: A Multicenter Prospective Cross-Sectional Study
Soo-Jin Cho et al.
HEADACHE (2017)
Framingham-Based Cardiovascular Risk Estimates Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study
Richard B. Lipton et al.
HEADACHE (2017)
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines
Joshua M. Cohen et al.
HEADACHE (2017)
Symptoms of central sensitization and comorbidity for juvenile fibromyalgia in childhood migraine: an observational study in a tertiary headache center
Marina de Tommaso et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies
Dimos D. Mitsikostas et al.
CURRENT OPINION IN NEUROLOGY (2017)
Calcitonin gene-related peptide monoclonal antibody for preventive treatment of episodic migraine: A meta analysis
Peiwei Hong et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2017)
A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability
Richard B. Lipton et al.
HEADACHE (2016)
Impact of migraine on fibromyalgia symptoms
Maria Adele Giamberardino et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points
Marcelo E. Bigal et al.
NEUROLOGY (2016)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Another Case of Lower Back Pain Associated With Migraine: The Importance of Specific Questions
Yosuke Kakisaka et al.
JOURNAL OF CHILD NEUROLOGY (2013)
Modified Valsalva test differentiates primary from secondary cough headache
Enrico Ferrante
JOURNAL OF HEADACHE AND PAIN (2013)
CGRP and migraine: Could PACAP play a role too?
Eric A. Kaiser et al.
NEUROPEPTIDES (2013)
Chronic migraine and chronic tension-type headache are associated with concomitant low back pain: Results of the German Headache Consortium study
Min-Suk Yoon et al.
PAIN (2013)
Migraine in women with chronic pelvic pain with and without endometriosis
Barbara Illowsky Karp et al.
FERTILITY AND STERILITY (2011)
Current practice and future directions in the prevention and acute management of migraine
Peter J. Goadsby et al.
LANCET NEUROLOGY (2010)
CGRP and its receptors provide new insights into migraine pathophysiology
Tony W. Ho et al.
NATURE REVIEWS NEUROLOGY (2010)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Share Paper
